SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-29
👔
Monopar Therapeutics
@MNPR_InsiderForm 4 Filing: Robinson Chandler Sells $3.2M of $MNPR
INSIDER SALE
⚡ MATERIALITY: 8/10
corporate issuer
Monopar Therapeutics
Ticker: $MNPR
Transaction Value
$3.2M
Price/Share: $54.87
transaction date
2026-09-24
Shares: 58,112
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Robinson Chandler, holds the title of Chief Executive Officer at Monopar Therapeutics.
On 2026-09-24, the insider transacted 58,112 shares.The shares were transacted at a weighted average price of $54.87 per share, resulting in a total market-relevant value of $3.2M.
Executive Summary Summary
Robinson Chandler (Chief Executive Officer) sold $3.2M of $MNPR
Post-Transaction Position: 117,873 shares
SEC Accession No: 0001437749-26-031411 (CIK: 1727334)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.